James Hardie Industries plc research snapshot
JHX AI stock analysis currently reads James Hardie Industries as a scaled exterior home and outdoor living products company after the July 2025 AZEK acquisition, not a clean pure-play fiber cement story. The stock closed at $24.79 on July 10, 2026, and market cap math verifies about $14.39 billion using 580.34 million shares outstanding. Fiscal 2026 net sales reached $4.836 billion, up 25% with AZEK, while organic net sales fell about 2% and GAAP net income fell to $104 million under deal, interest, and integration costs. Adjusted EBITDA of $1.266 billion and adjusted diluted EPS of $1.09 are the cleaner operating lenses. The JHX AI stock forecast hinges on housing and repair-remodel demand, AZEK synergy delivery, leverage reduction toward about 2.0x net debt, free cash flow recovery above $500 million in fiscal 2027, and whether investors re-rate the stock on adjusted earnings rather than depressed GAAP earnings.
Current price
$24.79
Market cap
$14.39 billion verified market cap
AI score
62 / 100
Rating
High-quality exterior building products franchise post AZEK, with integration and housing-cycle risks still capping conviction
Trend status
Repairing intermediate trend after a deep 2025 drawdown, with price near the mid-$20s and recently reclaiming the 200-day moving average zone while still well below the 2024 peak
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | James Hardie sells fiber cement siding, trim, and related exterior products, now combined with AZEK outdoor living brands such as TimberTech decking, so customers pay for durable, low-maintenance exterior and outdoor surfaces. | High |
| Moat | The moat comes from brand preference among builders and remodelers, category expertise in fiber cement and composite outdoor living, manufacturing scale, distribution relationships, and product performance claims that are costly to displace quickly. | Medium-high |
| Management | CEO Aaron Erter is being judged on AZEK integration, Hardie Operating System manufacturing gains, channel discipline, free cash flow recovery, and bringing net leverage down after a large cash-and-stock deal. | Medium |
| Financial trend | Fiscal 2026 net sales rose 25% to $4.836 billion, but organic sales declined about 2%, operating income fell 32% to $447.6 million, and GAAP net income fell to $104 million while adjusted EBITDA reached $1.266 billion. | High |
| Valuation | At $24.79, audited math shows about 22.7x fiscal 2026 adjusted EPS of $1.09, versus about 130x depressed GAAP EPS near $0.19. Adjusted earnings are the more usable lens during integration. | Medium-high |
| Technical trend | Price sits in the mid-$20s after reclaiming the 200-day area, with a 52-week range of about $16.46 to $29.83 and resistance still well below the 2024 peak near $42. | Medium |
| Risk level | Risk is elevated to moderate-high. Housing cycles, AZEK integration, higher debt, asbestos funding needs, channel inventory swings, and competition from vinyl, engineered wood, and other exterior products can all hurt returns. | Medium-high |
| AI confidence | Descriptive data confidence is high because company results and multi-source financials are current. Return confidence is lower because the bull case needs organic recovery plus clean synergy delivery. | High data confidence |
| Investment certainty | JHX screens as a quality building products franchise in transition, not a no-brainer deep value setup. Certainty improves if organic volumes stabilize, free cash flow exceeds $500 million, and leverage trends toward the stated 2.0x target. | Medium-low |
JHX AI stock forecast
The JHX AI stock forecast uses the $24.79 price reference, fiscal 2026 adjusted diluted EPS of $1.09, and a three-year earnings multiple framework. The audited model produced a bearish value near $15, a base value near $29, and a bullish value near $43 before dividends. These are scenario ranges, not price promises.
$40 to $45
More likely if organic volumes recover, AZEK cost and commercial synergies land as planned, fiscal 2027 adjusted EBITDA reaches the high end of the $1.45 to $1.50 billion guide, free cash flow exceeds $500 million, leverage falls toward 2.0x, and the market awards JHX a high-20s earnings multiple on growing adjusted EPS.
$27 to $31
More likely if net sales grow roughly in line with the $5.25 to $5.41 billion fiscal 2027 sales guide, adjusted EBITDA compounds in the mid-single-digit to high-single-digit range from the adjusted base, channel inventory normalizes, and the stock trades near a low-20s multiple on adjusted earnings.
$14 to $17
More likely if U.S. housing and repair-remodel demand weaken further, organic volumes keep falling, synergy capture disappoints, interest and asbestos cash needs pressure free cash flow, leverage stays elevated, or investors re-rate JHX toward a mid-teens multiple on stalled earnings.
JHX AI technical analysis
JHX AI technical analysis uses market and technical data available at the July 12, 2026 cutoff. Company and market sources placed the July 10, 2026 close near $24.79, with a 52-week range of about $16.46 to $29.83. MarketBeat noted a move above the 200-day moving average in early July 2026, while shorter-term momentum remained mixed after a sharp 2025 drawdown from the 2024 high near $42. The setup is a damaged long-term chart trying to rebuild intermediate trend support in the mid-$20s.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $24.79 | July 10, 2026 company IR closing price used for market cap verification. |
| Immediate support | $23.86 to $24.35 | Recent session lows and the lower end of the early July trading range form the first short-term support band. |
| Secondary support | $22.11 | Near the June 2026 swing area and the lower end of the one-month range reported by ChartMill. |
| Major support | $16.46 to $19.66 | The 52-week low zone and deeper ChartMill support form the key long-term invalidation band if the rebuild fails. |
| Near resistance | $25.40 to $26.63 | ChartMill and recent swing highs mark the first overhead supply after the 200-day reclaim attempt. |
| Breakout resistance | $29.83 | The 52-week high is the key upside confirmation level before any discussion of a fuller recovery toward the prior multi-year peak. |
| Momentum | RSI near neutral to soft | Investing.com data around early July showed RSI near the mid-40s, consistent with a stock rebuilding rather than extending a strong uptrend. |
| Volume | Elevated multi-million share average volume | Yahoo Finance and Motley Fool data pointed to average volume near 7.5 million shares, so liquidity is adequate for active monitoring. |
| Volatility | 52-week range $16.46 to $29.83 | The stock remains far below the September 2024 high near $42, so residual volatility and valuation re-rating risk remain high. |
| Invalidation | Close below $22.11 | A decisive close below the June swing support would weaken the intermediate rebuild and shift attention back toward the low-$20s and high-teens risk zone. |
JHX AI trading strategy
The JHX AI trading strategy below is a rules-based research framework, not personal advice. It connects trend levels with housing demand, AZEK integration, channel inventory, adjusted EBITDA, free cash flow, leverage, asbestos cash needs, and valuation discipline.
Watch for JHX to hold above $23.86 to $24.35, reclaim and hold $25.40 to $26.63, and later challenge $29.83 while company updates confirm organic volume stabilization, synergy delivery, and free cash flow progress.
A close below $22.11, weaker housing indicators, failed synergy updates, or evidence that leverage is not trending lower should reduce trend-following confidence.
If JHX pulls back toward $22 to $23 without a change in fiscal 2027 guidance, synergy trackers, or free cash flow targets, compare the entry price with the audited base scenario and the adjusted earnings multiple rather than the distorted GAAP P/E.
Do not treat a pullback as cheap if organic volumes keep falling, channel inventory builds again, debt metrics worsen, or peers show broader exterior products demand pressure.
Track organic net sales, Siding and Trim volumes, Deck Rail and Accessories sell-through, adjusted EBITDA versus the $1.45 to $1.50 billion fiscal 2027 range, free cash flow versus the $500 million-plus target, net leverage, asbestos cash outflows, and share count stability after the AZEK equity issuance.
Position sizing should reflect that JHX is a higher-quality building products franchise in a post-deal transition, not an assured compounder at any price.
Investment research summary
Customers pay James Hardie because fiber cement and outdoor living products promise longer-lasting, lower-maintenance exteriors and outdoor surfaces than many traditional wood or vinyl alternatives.
The moat is built from brand strength with builders and remodelers, manufacturing scale, distribution reach, product category expertise, and the expanded outdoor living platform after AZEK, though substitution by competing exterior materials remains real.
The thesis fails if housing and repair-remodel demand stay weak, AZEK synergies underdeliver, leverage and asbestos cash needs consume free cash flow, channel inventory turns into another production cut, or investors decide the post-deal story is still too cyclical for a premium multiple.
Aaron Erter has led James Hardie since September 2022 and is now judged on AZEK integration quality, operating system gains, capital allocation under higher debt, and the ability to restore free cash flow without sacrificing long-term product position.
U.S. residential exteriors and outdoor living sit inside long-run repair, remodel, and climate-driven material upgrade demand. The long-term category is durable, but the near-term path still runs through housing starts, mortgage rates, weather, and dealer inventory cycles.
At $24.79, JHX is no longer priced at the 2024 peak optimism, but it is also not a pure bargain if organic growth stays negative. Margin of safety improves if adjusted earnings grow, free cash flow exceeds $500 million, and leverage trends toward the stated 2.0x target.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| JHX quote reference | $24.79 stock price at the July 10, 2026 close | James Hardie NYSE stock info and Macrotrends price history | July 12, 2026 |
| Market capitalization verification | $14.39 billion calculated from $24.79 x 580.34 million shares, with 0.00% variance versus the rounded reported market cap | Pineify financial_rigor.py and MarketWatch overview | July 12, 2026 |
| Shares outstanding | 580.34 million shares outstanding after the AZEK cash-and-stock combination | MarketWatch and Yahoo Finance key statistics | July 12, 2026 |
| FY2026 net sales | $4.8358 billion, up 25% year over year, cross-validated against Macrotrends and Yahoo with 0.00% variance | Company FY26 results summary via TradingView and Macrotrends | July 12, 2026 |
| FY2026 organic sales and net income | Organic net sales down about 2%, GAAP net income $104.0 million, and Q4 net income $28.5 million | Company FY26 results summary via TradingView and Yahoo Finance | July 12, 2026 |
| FY2026 adjusted operating metrics | Adjusted EBITDA $1,265.8 million and adjusted diluted EPS $1.09 for fiscal 2026 | Company FY26 results summary via TradingView SEC summary | July 12, 2026 |
| Cash flow and capex | FY26 operating cash flow $589.8 million and capital expenditures $383.9 million | Company FY26 results summary via TradingView SEC summary | July 12, 2026 |
| Debt and asbestos context | Post-AZEK long-term debt rose into the multi-billion range, with asbestos restricted cash and liabilities still material on the balance sheet | Company Q3 FY26 release and FY26 results balance sheet notes | July 12, 2026 |
| AZEK acquisition | AZEK deal closed July 1, 2025 in a cash-and-stock transaction with implied equity value near $8.4 billion plus debt assumptions | James Hardie press release on AZEK completion | July 12, 2026 |
| FY2027 guidance | Net sales targeted at $5.25 to $5.41 billion, adjusted EBITDA at $1.45 to $1.50 billion, free cash flow above $500 million, and net leverage toward about 2.0x by end of Q2 FY28 | Company FY26 results and FY27 outlook summary | July 12, 2026 |
| Valuation math | 22.7x fiscal 2026 adjusted EPS of $1.09, versus about 130x depressed GAAP EPS near $0.19; three-scenario values near $15, $29, and $43 | Pineify financial_rigor.py valuation and three-scenario tools | July 12, 2026 |
| Technical range | 52-week range about $16.46 to $29.83, with July 2026 price reclaiming the 200-day moving average area after the 2025 drawdown | MarketWatch, ChartMill, and MarketBeat technical notes | July 12, 2026 |
This JHX AI stock analysis page is an informational research tool only. It is not investment advice, financial advice, or a recommendation to buy or sell James Hardie Industries securities. Forecast scenarios are based on available public data, audited calculations, and assumptions that can be wrong. Always do your own research and consider speaking with a qualified financial advisor before making investment decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
